Minimizing the role of cryoprotectant toxicity for cryopreservation
Minimizing the role of cryoprotectant toxicity for cryopreservation
批准号:
8925076
负责人:
Utkan Demirci
金额:
$38.94万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2016-06-30
关键词:
AnimalsAreaBiodiversityBiological AssayBiological PreservationBloodBlood BanksCaringCell VolumesCellsClinicClinicalCouplesCryopreservationDevicesDiffusionExcisionFertilityFreezingGerm CellsGoalsHepatocyteHumanIceIn VitroInfertilityKnowledgeLeadLifeManualsMechanicsMembraneMethodsMicrofluidicsOocytesOsmotic ShocksOutcomeOutcome StudyProcessPublishingRegenerative MedicineReproductive MedicineRoleSamplingStem cellsSystemTechnologyTissue EngineeringTissuesToxic effectTrainingVariantWorkbasecell injurycell typeclinically significantcytotoxicdrug testingimprovedisletnanolitrenew technologynovelnovel strategiessperm celltransplantation medicine
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Long-term biopreservation of cells and tissues has a broad impact in multiple fields including tissue engineering, regenerative medicine, stem cells, blood banking, animal strain preservation (biodiversity protection), clinical sample storage, transplantation medicine and in vitro drug testing. Vitrification (ice/crystal-free cryopreservatio) has emerged as a novel approach over traditional slow freezing methods. Although vitrification minimizes mechanical damage due to ice crystal nucleation, it suffers from toxicity due to high concentrations of cryoprotectant agents (CPAs). The current vitrification methods require extremely high levels of CPAs of up to 8.2 M that are cytotoxic and cause osmotic shock. Also, the lengthy manual processing steps of current vitrification methods add to the technical complexity, require highly trained technicians, and result in variations between users. For instance, low CPA-level vitrification has immense potential for the stem cells compared to other methods in preserving their functionality. Recently, we demonstrated that we can achieve vitrification at ultra-rapid freezing and thawing rates with as low as 1.5M CPA concentration. We are adapting this new knowledge to the vital needs of cell cryopreservation at the clinic including
discarded anonymous human oocytes. This proposal investigates a new experimental strategy to minimize the CPA concentrations and improve clinical outcomes using novel technologies (i.e., nanoliter droplet vitrification). These steps are facilitated by theoretical understanding o the underlying mechanisms governing vitrification. The expected outcome of this study is a closed-system platform technology with broad applications to human cell (e.g., hepatocytes, oocytes, sperm, stem cells), tissues (e.g., blood), micro-tissues (e.g., embryoid bodies, islets) covering areas of reproductive medicine, tissue engineering and regenerative medicine as well as to wild life preservation. These studies can also significantly impact the care of infertile couples and facilitate fertility preservation.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1002/term.2439
发表时间:
2018-01
期刊:
Journal of tissue engineering and regenerative medicine
影响因子:
3.3
作者:
[Choi JK, El Assal R, Ng N, Ginsburg E, Maas RL, Anchan RM, Demirci U]
通讯作者:
Demirci U
DOI:
10.1016/j.tibtech.2015.02.003
发表时间:
2015-05
期刊:
TRENDS IN BIOTECHNOLOGY
影响因子:
17.3
作者:
[Guven, Sinan, Chen, Pu, Inci, Fatih, Tasoglu, Saves, Erkmen, Burcu, Demirci, Utkan]
通讯作者:
Demirci, Utkan
DOI:
10.1002/adma.201405660
发表时间:
2015-07-08
期刊:
Advanced materials (Deerfield Beach, Fla.)
影响因子:
--
作者:
[Tasoglu S, Khoory JA, Tekin HC, Thomas C, Karnoub AE, Ghiran IC, Demirci U]
通讯作者:
Demirci U
DOI:
10.1016/j.mattod.2015.05.002
发表时间:
2015-12
期刊:
Materials today (Kidlington, England)
影响因子:
--
作者:
[Asghar W, El Assal R, Shafiee H, Pitteri S, Paulmurugan R, Demirci U]
通讯作者:
Demirci U
DOI:
10.1002/biot.201300074
发表时间:
2014-07
期刊:
BIOTECHNOLOGY JOURNAL
影响因子:
4.7
作者:
[Asghar, Waseem, El Assal, Rami, Shafiee, Hadi, Anchan, Raymond M., Demirci, Utkan]
通讯作者:
Demirci, Utkan
共 15 条
NOVEL EXOSOME BIOMARKERS OF IRON PATHOLOGY IN AD
-
批准号:10223789
-
项目类别:
-
资助金额:$43.3万
-
财政年份:2021
-
负责人:Utkan Demirci
-
依托单位:
CANARY CANCER RESEARCH EDUCATION SUMMER TRAINING (CANARY CREST) PROGRAM
-
批准号:10462468
-
项目类别:
-
资助金额:$23.67万
-
财政年份:2017
-
负责人:Utkan Demirci
-
依托单位:
CANARY CANCER RESEARCH EDUCATION SUMMER TRAINING (CANARY CREST) PROGRAM
-
批准号:10713237
-
项目类别:
-
资助金额:$41.86万
-
财政年份:2017
-
负责人:Utkan Demirci
-
依托单位:
CANARY CANCER RESEARCH EDUCATION SUMMER TRAINING (CANARY CREST) PROGRAM
-
批准号:9358372
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2017
-
负责人:Utkan Demirci
-
依托单位:
CANARY CANCER RESEARCH EDUCATION SUMMER TRAINING (CANARY CREST) PROGRAM
-
批准号:9762061
-
项目类别:
-
资助金额:$23.67万
-
财政年份:2017
-
负责人:Utkan Demirci
-
依托单位:
CANARY CANCER RESEARCH EDUCATION SUMMER TRAINING (CANARY CREST) PROGRAM
-
批准号:9995434
-
项目类别:
-
资助金额:$19.78万
-
财政年份:2017
-
负责人:Utkan Demirci
-
依托单位:
Single Cell Characterization of Latent HIV-1 Reservoirs
-
批准号:9324120
-
项目类别:
-
资助金额:$37.86万
-
财政年份:2016
-
负责人:Utkan Demirci
-
依托单位:
A Novel Microfluidic HIV-1 Co-Culture Assay to Quantify Latent Reservoirs
-
批准号:8768888
-
项目类别:
-
资助金额:$22.62万
-
财政年份:2014
-
负责人:Utkan Demirci
-
依托单位:
Microfluidic PCR Method to Identify and Characterize HIV-Infected Single Cells
-
批准号:8790281
-
项目类别:
-
资助金额:$22.62万
-
财政年份:2014
-
负责人:Utkan Demirci
-
依托单位:
Novel disposable microchips for HIV-1 viral load
-
批准号:8943940
-
项目类别:
-
资助金额:$41.64万
-
财政年份:2012
-
负责人:Utkan Demirci
-
依托单位:
Novel disposable microchips for HIV-1 viral load
-
批准号:8411025
-
项目类别:
-
资助金额:$44.63万
-
财政年份:2012
-
负责人:Utkan Demirci
-
依托单位:
Minimizing the role of cryoprotectant toxicity for cryopreservation
-
批准号:8387929
-
项目类别:
-
资助金额:$39.74万
-
财政年份:2012
-
负责人:Utkan Demirci
-
依托单位:
Minimizing the role of cryoprotectant toxicity for cryopreservation
-
批准号:8890272
-
项目类别:
-
资助金额:$5.6万
-
财政年份:2012
-
负责人:Utkan Demirci
-
依托单位:
Minimizing the role of cryoprotectant toxicity for cryopreservation
-
批准号:8516040
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2012
-
负责人:Utkan Demirci
-
依托单位:
Minimizing the role of cryoprotectant toxicity for cryopreservation
-
批准号:8686838
-
项目类别:
-
资助金额:$38.55万
-
财政年份:2012
-
负责人:Utkan Demirci
-
依托单位:
Novel disposable microchips for HIV-1 viral load
-
批准号:8508178
-
项目类别:
-
资助金额:$41.95万
-
财政年份:2012
-
负责人:Utkan Demirci
-
依托单位:
Novel disposable microchips for HIV-1 viral load
-
批准号:8681305
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Utkan Demirci
-
依托单位:
Microfluidic Chip for Cryopreservation of Blood Cells
-
批准号:8191888
-
项目类别:
-
资助金额:$26.76万
-
财政年份:2011
-
负责人:Utkan Demirci
-
依托单位:
Microfluidic Chip for Cryopreservation of Blood Cells
-
批准号:8280375
-
项目类别:
-
资助金额:$22.31万
-
财政年份:2011
-
负责人:Utkan Demirci
-
依托单位:
Antibody-based cell purification at resource limited setting for HIV
-
批准号:8024526
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2010
-
负责人:Utkan Demirci
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: